Literature DB >> 33241617

Higher content of microcystin-leucine-arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients.

Shen Gu1,2,3,4, Wei He5, Minghao Yan2,3, Jian He6, Qun Zhou6, Xiaopeng Yan1, Xiao Fu1,2,3, Jun Chen7, Xiaodong Han2,3, Yudong Qiu1.   

Abstract

BACKGROUND & AIMS: Intrahepatic cholangiocarcinoma (ICC) has over the last 10 years become the focus of increasing concern largely due to its rising incidence and high mortality rates worldwide. Microcystin-leucine-arginine (MC-LR) has been reported to be carcinogenic, but there are no data on the linkage between MC-LR and ICC. This study aimed to explore whether the content levels of MC-LR in the tumour tissues of ICC patients be associated with the prognosis and if so, to characterize the mechanism in ICC cells.
METHODS: We conducted a retrospective study to evaluate the prognostic value of MC-LR in ICC after resection. All patients were divided into two groups according to the content of MC-LR in tumour via immunohistochemistry: low-MC-LR group (n = 28) and high-MC-LR group (n = 30).
RESULTS: Multivariate analysis showed high-MC-LR level was the prognostic factor for OS and RFS after hepatectomy (P = .011 and .044). We demonstrated that MC-LR could promote the survival of human ICC cell lines and SET was identified as an important mRNA in the progression via RNA array.
CONCLUSIONS: We provide evidence that MC-LR was an independent prognostic factor for ICC in humans by modulating the expression of SET in human ICC cells.
© 2020 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PP2A; SET; intrahepatic cholangiocarcinoma; microcystin-leucine-arginine; prognosis

Mesh:

Substances:

Year:  2020        PMID: 33241617      PMCID: PMC7848955          DOI: 10.1111/cpr.12961

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  37 in total

Review 1.  Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.

Authors:  Alphonse E Sirica; Gregory J Gores
Journal:  Hepatology       Date:  2014-04-09       Impact factor: 17.425

Review 2.  The role of PP2A-associated proteins and signal pathways in microcystin-LR toxicity.

Authors:  Jing Liu; Yu Sun
Journal:  Toxicol Lett       Date:  2015-04-25       Impact factor: 4.372

3.  PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.

Authors:  Otto Kauko; Caitlin M O'Connor; Evgeny Kulesskiy; Jaya Sangodkar; Anna Aakula; Sudeh Izadmehr; Laxman Yetukuri; Bhagwan Yadav; Artur Padzik; Teemu Daniel Laajala; Pekka Haapaniemi; Majid Momeny; Taru Varila; Michael Ohlmeyer; Tero Aittokallio; Krister Wennerberg; Goutham Narla; Jukka Westermarck
Journal:  Sci Transl Med       Date:  2018-07-18       Impact factor: 17.956

Review 4.  Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.

Authors:  Michael N Mavros; Konstantinos P Economopoulos; Vangelis G Alexiou; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2014-06       Impact factor: 14.766

5.  MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors.

Authors:  Sofia S Pereira; Mariana P Monteiro; Madalena M Costa; Jorge Ferreira; Marco G Alves; Pedro F Oliveira; Ivana Jarak; Duarte Pignatelli
Journal:  J Cell Biochem       Date:  2018-09-06       Impact factor: 4.429

6.  The role of IL-8/CXCR2 signaling in microcystin-LR triggered endothelial cell activation and increased vascular permeability.

Authors:  Limei Chen; Xiaoying Liu; Zhifang Pan; Shunmei Liu; Huirong Han; Chunling Zhao; Xuexi Tang
Journal:  Chemosphere       Date:  2017-11-25       Impact factor: 7.086

7.  Chronic Microcystin-LR Exposure Induces Hepatocarcinogenesis via Increased Gankyrin in Vitro and in Vivo.

Authors:  Lixiong He; Yujing Huang; Qiaonan Guo; Hui Zeng; Chuanfen Zheng; Jia Wang; Ji-An Chen; Lingqiao Wang; Weiqun Shu
Journal:  Cell Physiol Biochem       Date:  2018-09-11

8.  A sequence-based identification of the genes detected by probesets on the Affymetrix U133 plus 2.0 array.

Authors:  Jeremy Harbig; Robert Sprinkle; Steven A Enkemann
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

9.  Impact of Microcystin-LR on Liver Function Varies by Dose and Sex in Mice.

Authors:  Igor Mrdjen; Mark A Morse; Randall J Ruch; Thomas J Knobloch; Shambhunath Choudhary; Christopher M Weghorst; Jiyoung Lee
Journal:  Toxins (Basel)       Date:  2018-10-28       Impact factor: 4.546

10.  Higher content of microcystin-leucine-arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients.

Authors:  Shen Gu; Wei He; Minghao Yan; Jian He; Qun Zhou; Xiaopeng Yan; Xiao Fu; Jun Chen; Xiaodong Han; Yudong Qiu
Journal:  Cell Prolif       Date:  2020-11-25       Impact factor: 6.831

View more
  1 in total

1.  Higher content of microcystin-leucine-arginine promotes the survival of intrahepatic cholangiocarcinoma cells via regulating SET resulting in the poorer prognosis of patients.

Authors:  Shen Gu; Wei He; Minghao Yan; Jian He; Qun Zhou; Xiaopeng Yan; Xiao Fu; Jun Chen; Xiaodong Han; Yudong Qiu
Journal:  Cell Prolif       Date:  2020-11-25       Impact factor: 6.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.